细胞染色体P450反应的表型化:技术现状
1Pfizer Inc, Groton, CT, USA, 06340.
Drug metabolism and pharmacokinetics
|January 6, 2026
概括
细胞染色体P450反应表型化评估特定酶对药物代谢的贡献. 一种新的顺序方法改进了传统方法,解决了更好的药物开发洞察力的局限性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 生物化学 生物化学
背景情况:
- 细胞染色体P450 (P450) 反应表型是确定单个P450酶对药物代谢的贡献的关键体外方法.
- 已建立的方法利用选择性抑制剂,表达酶和人类肝脏系统 (微小体,肝细胞).
- 监管机构需要P450表型数据来批准新药候选药物,以告知患者安全和临床试验设计.
研究的目的:
- 评估当前P450反应表型化方法的局限性.
- 介绍和讨论一种新的顺序定性-然后-定量方法,用于P450反应表型化.
- 提出一个更全面的实验设计,考虑到抑制剂选择性问题.
主要方法:
- 审查已建立的P450反应表型化技术 (抑制剂,表达酶,体外系统).
- 描述一种新的顺序定性-然后-定量方法.
- 考虑解决不完全抑制剂选择性的实验设计.
主要成果:
- 传统的P450表型化方法有缺点,包括抑制剂选择性问题,基质依赖的缩放因子,以及低周转基质的挑战.
- 顺序方法提供了改进,但仍然需要在更广泛的体内处置特征中考虑P450贡献.
- 非P450清除途径 (例如,活性运输) 仍然是整体药物处置的重要因素.
结论:
- 对于药物开发来说,P450反应表型化是必不可少的,它提供了关键的安全性和药理动力学数据.
- 新的顺序方法通过解决特定的局限性来增强当前的方法.
- 将P450表型化结果与体内数据 (例如放射性标记ADME研究) 的整合对于完全了解药物处置至关重要.
更多相关视频
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
10.2K
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
Published on: November 23, 2011
37.6K
相关概念视频
01:17Drug Metabolism: Phase I Reactions
4.6K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.6K
01:19Phase I Oxidative Reactions: Overview
703
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
703
01:17Oxidation of Phenols to Quinones
4.5K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
4.5K
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
682
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
682